Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis.

Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. Abstract Text:

    yvonne iboldYvonne Ibold,simone frauenschuhSimone Frauenschuh,christian kapsChristian Kaps,michael sittingerMichael Sittinger,jochen ringeJochen Ringe,peter m goetzPeter M Goetz,yvonne iboldYvonne Ibold,simone frauenschuhSimone Frauenschuh,christian kapsChristian Kaps,michael sittingerMichael Sittinger,jochen ringeJochen Ringe,peter m goetzPeter M Goetz,

    The 3-dimensional (3-D) pannus model for rheumatoid arthritis (RA) is based on the interactive co-culture of cartilage and synovial fibroblasts (SFs). Besides the investigation of the pathogenesis of RA, it can be used to analyze the active profiles of antirheumatic pharmaceuticals and other bioactive substances under in vitro conditions. For a potential application in the industrial drug-screening process as a transitional step between 2-dimensional (2-D) cell-based assays and in vivo animal studies, the pannus model was developed into an in vitro high-throughput screening (HTS) assay. Using the CyBitrade mark-Disk workstation for parallel liquid handling, the main cell culture steps of cell seeding and cultivation were automated. Chondrocytes were isolated from articular cartilage and seeded directly into 96-well microplates in high-density pellets to ensure formation of cartilage-specific extracellular matrix (ECM). Cell seeding was performed automatically and manually to compare both processes regarding accuracy, reproducibility, consistency, and handling time. For automated cultivation of the chondrocyte pellet cultures, a sequential program was developed using the CyBio Control software to minimize shear forces and handling time. After 14 days of cultivation, the pannus model was completed by coating the cartilage pellets with a layer of human SFs. The effects due to automation in comparison to manual handling were analyzed by optical analysis of the pellets, histological and immunohistochemical staining, and real-time PCR. Automation of this in vitro model was successfully achieved and resulted in an improved quality of the generated pannus cultures by enhancing the formation of cartilage-specific ECM. In addition, automated cell seeding and media exchange increased the efficiency due to a reduction of labor intensity and handling time.

    Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. Publishing Authors By Initials

    y iboldY Ibold,s frauenschuhS Frauenschuh,c kapsC Kaps,m sittingerM Sittinger,j ringeJ Ringe,pm goetzPM Goetz,y iboldY Ibold,s frauenschuhS Frauenschuh,c kapsC Kaps,m sittingerM Sittinger,j ringeJ Ringe,pm goetzPM Goetz,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of biomolecular screening : the official j

    VOLUME: 12

    Page Numbers: 956-65

    Journal Abbreviation:

    ISSN: 1087-0571

    DAY: 18

    MONTH: Oct

    YEAR: 2007

    Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9612112

    Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis.

    AFFILIATION: Department of Bioprocess Engineering, Institute of Biotechnology, Technical University of Berlin, Germany.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Biomol Screen

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Development of a high-throughput screening assay based on the 3-dimensional pannus model for rheumatoid arthritis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News